CompoAtlas

CONFORT URINAIRE

Food supplement declared in France, declaration No 2020-7-348, decision dated 6 July 2020

CONFORT URINAIRE (WELL PHARMA) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
WELL PHARMA
Food business operator placing the product on the market
WELLPHARMA
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
2 gélules par jour
Directions for use
Prendre 2 gélules par jour avec un grand verre d’eau.
Intended populations
Homme, Femme
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Insuffisance rénale, Utilisation prolongée
Objectives stated by the manufacturer (these are not authorised claims)
Système urinaire

Declaration 289798, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Vaccinium macrocarpon AitonFruitAutre extrait sec360 mg
Erica cinerea L.Sommités fleuriesExtrait sec aqueux100 mg
Arctostaphylos uva-ursi (L.) Spreng.FeuilleExtrait sec aqueux100 mg
Coriandrum sativum L.FruitPoudre (de plantes séchées ou broyées)100 mg

Additives

E470b, E464

Other ingredients

maltodextrine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

Déconseillé chez les enfants, les adolescents, les femmes enceintes et allaitantes, ainsi que chez les personnes souffrant d'insuffisance rénale ; ne pas dépasser une semaine d'utilisation.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.

Brand : WELL PHARMA

List recorded in 2020. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line